REGISTRATIONS OPEN
Register here.

PRESENTER INSTRUCTIONS
Available here.

DATE AND LOCATION
Thursday 14^th – Friday 15^th December 2023. The 25^th anniversary 2023 Workshop will take place at the brand new, state-of-the-art meeting space offered by Johns Hopkins School of Advanced International Studies (SAIS), 555 Pennsylvania Avenue NW, Washington, D.C., USA.

The 2023 Career Development Studio for Early Stage Investigators will take place on Wednesday 13^th December 2023.

2023 SUBMISSIONS FOR THE COOPER SCHOLARSHIP, THE CAREER DEVELOPMENT STUDIO & ABSTRACTS ARE NOW CLOSED.

CME ACCREDITATION 
Please visit the CME information tab for further information.

ABOUT THE WORKSHOP
Now in its 25^th consecutive year, the International Workshop on Long-term Complications of HIV and SARS-CoV-2 continues to serve as an international arena for the presentation and discussion of scientific and clinical data on metabolic complications, lipodystrophy, co-morbidities and related topics in HIV and SARS-CoV-2. The need for continued discussion and sharing of experiences in caring for HIV-infected individuals remains, and this Workshop continues to provide the ideal setting. 

A wide range of professionals from across the world, from physicians and scientists to community groups and industry personnel will again attend the Workshop. Delegates can engage in a combination of plenary sessions and presentations selected from abstracts, poster sessions and extensive discussion periods in order to facilitate peer-to-peer interactions and shared learnings.

2023 SUPPORTERS

ViiV Healthcare

This conference was partially supported by the Office of AIDS Research, the National Heart, Lung, and Blood Institute, and the National Institute of Allergy and Infectious Diseases (R13HL172622) of the National Institutes of Health. The views expressed in conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices or organizations imply endorsement by the US Government.